益智药市场－全球产业规模、份额、趋势、机会和预测：按类型、产品类型、分销管道、应用、地区和竞争格局划分，2021-2031年

全球益智药市场预计将大幅成长，从 2025 年的 75.5 亿美元成长到 2031 年的 165.8 亿美元，复合年增长率为 14.01%。

人们对益智药（包括天然或药物成分，旨在增强创造力、记忆力和积极性等认知能力）的需求日益增长，这主要源于老年人希望延缓神经退化性疾病的进展，以及专业希望最大限度地提高思维效率。这种对大脑健康的浓厚兴趣正在产生实际的市场效益。例如，美国植物委员会 (ABC) 报告称，2024 年，主流零售通路中专注于认知健康的蘑菇补充剂销量激增 114.5%。

然而，由于各国监管体系复杂多元，该产业面临许多挑战。天然化合物和合成化合物缺乏统一的分类标准，造成了市场准入壁垒，使全球分销规划更加复杂，并增加了遵循成本。严格的安全标准和标籤要求往往会延迟产品上市，阻碍製造商快速掌握新的国际市场机会。

市场驱动因素

随着玩家积极寻求能够提升精神耐力、专注力和反应速度的补剂，益智药在竞技游戏和电竞领域的日益普及正在从根本上改变市场格局。这种人口结构的变化正推动认知增强剂从专业药品走向主流消费品，尤其是一些含有α-GPC和L-酪胺酸等成分的即饮能量饮料。大型饮料公司正积极顺应这一趋势，透过收购游戏品牌来巩固市场占有率。例如，Curig Dr Pepper在2025年10月发布的「2025财年第三季财报」中指出，其对生活方式能量饮料品牌Ghost的收购为其总销售量和构成比增长贡献了7.2个百分点，凸显了该品类巨大的商业性影响力。

同时，人们对合成兴奋剂的质疑以及对全面脑健康解决方案的偏好，导致植物来源和天然配方产品越来越受欢迎。这种转变重新激发了人们对药用蘑菇和传统适应原的兴趣。这些产品现在被作为提升思维清晰度和缓解压力的优质辅助品进行销售，製造商也推出了越来越多的「洁净标示」产品，这些产品在提供神经保护功效的同时，避免了高咖啡因产品的副作用。 Vitamin Shoppe 于 2025 年 6 月发布的《2025 年健康与保健趋势报告》显示，用于认知支持的喜来芝销量在第一季增长了 40%。此外，协和发酵工业株式会社 (Kyowa Hakko Kogyo) 于 2025 年 1 月发表的一篇报导指出，53% 的消费者对旨在促进大脑健康的饮品特别感兴趣。

市场挑战

全球益智药市场受到国际司法管辖区复杂且差异巨大的法律规范的严重限制。製造商必须应对不一致的分类，某些化合物在一些国家核准为膳食补充剂，而在其他国家则被限制为药品。这种监管碎片化迫使企业投入巨资进行配方改良并制定区域策略，从而耗费大量资金并延长产品上市时间。因此，这阻碍了统一的全球宣传活动的实施，并减缓了产业的扩张。

鑑于消费者对认知支援产品的需求快速成长，这种监管摩擦尤其有害。根据责任营养委员会 (CRN) 2024 年的数据，作为益智药类别关键成分的睡茄的使用率已达到膳食补充剂用户的 8%，短短四年内增长了四倍。然而，当严格的合规标准和核准延迟限制了这些高需求成分的供应时，製造商不仅错失了重要的市场机会，还遭受了巨大的收入损失，并且由于供应无法满足激增的消费者需求，阻碍了整体市场扩张。

市场趋势

企业正越来越多地利用机器学习演算法和人工智慧来分析消费者的基因图谱、生活方式数据和生物识别讯息，从而开发针对特定认知目标的客製化促智配方。这项创新实现了动态的营养补充方案，能够根据用户不断变化的生理需求进行调整，标誌着「一刀切」式复合综合维他命的时代正在发生重大转变。 ADM 于 2025 年 8 月发布的报告《推动功能性零食市场的四大因素》显示，市场对这种个人化解决方案的需求非常强劲，59% 的全球消费者希望获得根据其独特营养需求量身定制的产品。

除了饮料之外，功能性零食、口腔吸收片、口香糖和益智软糖等替代给药形式正变得越来越受欢迎，以提高遵守用药和适口性。製造商正积极拓展产品线，推出这些产品，以应对“片剂疲劳”，并吸引那些更喜欢方便、糖果状营养补充剂而非传统胶囊的年轻消费者。这种多元化发展正获得显着的商业性动力。例如，NutraIngredients 2025 年 5 月发表的一篇报导《软糖革命：蛋白质、美容和儿童营养领域的增长空间》报道称，Sirio Pharma 仅在亚太地区 2024 年的销售额就达到了约 4000 万美元，凸显了非片剂给药系统的快速普及。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球益智药市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（处方药与非处方药）
  • 依产品类型（天然系与合成）
  • 依分销管道（线上与线下）划分
  • 依用途分类（改善记忆力、情绪与忧郁症、注意力与专注力、延年益寿与老龄化、睡眠与恢復、焦虑、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美益智药市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲益智药市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区益智药市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲益智药市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲益智药市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球益智药市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Onnit
• Neurohacker Collective
• Mind Lab Pro
• Nootrogen
• HVMN
• Gaia Herbs
• NOW Foods
• Thorne
• GNC Holdings
• Natrol

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Nootropics Market is projected to experience substantial growth, expanding from USD 7.55 Billion in 2025 to USD 16.58 Billion by 2031, representing a compound annual growth rate of 14.01%. This rising demand for nootropics-defined as natural or pharmaceutical substances that improve cognitive abilities like creativity, memory, and motivation-is largely fueled by an aging demographic striving to slow neurodegenerative decline and professionals seeking to maximize mental efficiency. This keen interest in brain health is generating concrete market results; for example, the American Botanical Council reported that in 2024, sales of mushroom supplements focused on cognitive health surged by 114.5% within mainstream retail channels.

However, the industry encounters significant obstacles due to complicated and varying regulatory systems across different nations. The inconsistent categorization of natural versus synthetic compounds establishes major barriers to entry, thereby complicating global distribution plans and escalating compliance expenses. These rigorous safety standards and labeling mandates often postpone product releases, consequently hindering manufacturers' efforts to swiftly leverage emerging opportunities in new international regions.

Market Driver

The increasing use of nootropics within the competitive gaming and esports sectors is fundamentally transforming the market, as players actively seek supplements to improve mental endurance, focus, and reaction times. This demographic evolution has propelled cognitive enhancers from specialized pharmaceutical uses into mainstream consumer goods, notably via ready-to-drink energy beverages containing ingredients such as alpha-GPC and L-tyrosine. Major beverage corporations are aggressively pursuing this trend through acquisitions of gamer-focused brands to secure market share; for example, Keurig Dr Pepper noted in their October 2025 'Q3 2025 Results' that acquiring the lifestyle energy brand GHOST added 7.2 percentage points to their total volume/mix growth, underscoring the category's massive commercial influence.

Simultaneously, consumers are increasingly favoring plant-based and natural formulations due to skepticism regarding synthetic stimulants and a preference for holistic brain health solutions. This shift has renewed interest in medicinal mushrooms and traditional adaptogens, now marketed as premium aids for mental clarity and stress management, prompting manufacturers to release clean-label items offering neuroprotection without the side effects of high-caffeine products. The Vitamin Shoppe's 'Health and Wellness Trend Report 2025' from June 2025 highlighted a 40% Q1 increase in sales of shilajit for cognitive support, while a January 2025 article by Kyowa Hakko noted that 53% of consumers are specifically interested in beverages formulated for brain health.

Market Challenge

The Global Nootropics Market is severely constrained by complicated and divergent regulatory structures found across international jurisdictions. Manufacturers must navigate inconsistent classifications where a specific compound might be approved as a dietary supplement in one nation but restricted as a pharmaceutical in another. This regulatory fragmentation forces companies to invest in expensive reformulations and develop distinct regional strategies, which depletes financial resources and prolongs the time needed to bring products to market, ultimately preventing unified global campaigns and slowing industry expansion.

This regulatory friction is especially detrimental considering the rapid growth in consumer demand for cognitive support products. According to data from the Council for Responsible Nutrition in 2024, the use of ashwagandha-a key ingredient in the nootropic space-reached 8% among supplement users, representing a four-fold rise in just four years. However, when rigid compliance standards and approval delays restrict the supply of such high-demand ingredients, manufacturers fail to capitalize on critical market openings, leading to significant revenue loss and hindering broader market development as supply fails to meet the surging consumer appetite.

Market Trends

Companies are increasingly deploying machine learning algorithms and artificial intelligence to evaluate consumer genetic profiles, lifestyle data, and biometrics to create customized nootropic stacks that target specific cognitive objectives. This technological advancement enables the development of dynamic supplement regimens that adjust to a user's evolving physiological requirements, representing a significant shift away from static, one-size-fits-all multivitamins. There is substantial demand for such personalized solutions; as noted in ADM's 'Four Drivers Fueling the Functional Snacking Takeover' report from August 2025, 59% of global consumers have expressed a desire for products tailored to their unique nutritional needs.

Beyond beverages, there is a rising trend toward alternative delivery formats, such as functional snacks, oral strips, chewing gums, and nootropic-infused gummies, designed to enhance compliance and taste. Manufacturers are actively expanding their product lines with these options to combat "pill fatigue" and appeal to younger consumers who favor convenient, candy-like supplements over conventional capsules. This diversification is gaining significant commercial momentum; for instance, a May 2025 NutraIngredients article titled 'Gummy innovations: Protein, beauty, and kids nutrition offer room for growth' reported that Sirio Pharma achieved nearly USD 40 million in sales within the APAC region alone in 2024, highlighting the rapid adoption of non-pill delivery systems.

Key Market Players

• Onnit
• Neurohacker Collective
• Mind Lab Pro
• Nootrogen
• HVMN
• Gaia Herbs
• NOW Foods
• Thorne
• GNC Holdings
• Natrol

Report Scope

In this report, the Global Nootropics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nootropics Market, By Type

• Prescription v/s Over the Counter

Nootropics Market, By Product Type

• Natural v/s Synthetic

Nootropics Market, By Distribution Channel

• Online v/s Offline

Nootropics Market, By Application

• Memory Enhancement
• Mood & Depression
• Attention & Focus
• Longevity & Anti-aging
• Sleep & Recovery
• Anxiety
• Others

Nootropics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nootropics Market.

Available Customizations:

Global Nootropics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nootropics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Prescription v/s Over the Counter)
  • 5.2.2. By Product Type (Natural v/s Synthetic)
  • 5.2.3. By Distribution Channel (Online v/s Offline)
  • 5.2.4. By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Nootropics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nootropics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Distribution Channel
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Nootropics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Distribution Channel
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Nootropics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Distribution Channel
      • 6.3.3.2.4. By Application

7. Europe Nootropics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nootropics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Distribution Channel
      • 7.3.1.2.4. By Application
  • 7.3.2. France Nootropics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Distribution Channel
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Nootropics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Distribution Channel
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Nootropics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Distribution Channel
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Nootropics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Distribution Channel
      • 7.3.5.2.4. By Application

8. Asia Pacific Nootropics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Nootropics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Distribution Channel
      • 8.3.1.2.4. By Application
  • 8.3.2. India Nootropics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Distribution Channel
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Nootropics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Distribution Channel
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Nootropics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Distribution Channel
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Nootropics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Distribution Channel
      • 8.3.5.2.4. By Application

9. Middle East & Africa Nootropics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Nootropics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Distribution Channel
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Nootropics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Distribution Channel
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Nootropics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Distribution Channel
      • 9.3.3.2.4. By Application

10. South America Nootropics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Nootropics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Distribution Channel
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Nootropics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Distribution Channel
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Nootropics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Distribution Channel
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Nootropics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Onnit
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Neurohacker Collective
• 15.3. Mind Lab Pro
• 15.4. Nootrogen
• 15.5. HVMN
• 15.6. Gaia Herbs
• 15.7. NOW Foods
• 15.8. Thorne
• 15.9. GNC Holdings
• 15.10. Natrol

16. Strategic Recommendations

17. About Us & Disclaimer